adriana ramos - Epidemiology

Author Information

Adriana Ramos is affiliated with the National Cancer Registry and Epidemiology Research Unit at Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, located at Rua Professor Lima Basto, 1099-023, Lisboa, Portugal.

Research Contributions

Adriana Ramos has made significant contributions to the field of epidemiology, specifically focusing on cancer research. Her work spans various types of cancer, including advanced breast cancer, cutaneous malignant melanoma, chronic lymphocytic leukaemia, advanced melanoma, uterine carcinosarcoma, and non-small cell lung cancer. She has conducted population-based cohort studies to investigate real-world effectiveness and epidemiological and clinical characteristics of these cancers. Her research has been instrumental in understanding the utilization of treatments such as palbociclib, fulvestrant, and pembrolizumab in real-life settings, as well as screening methods for breast cancer.

Aliases

No aliases were provided for Adriana Ramos.

Publication and Citation Metrics

Metrics	Value
Total Papers	9
Total Citations	11
H-Index	2

Publications:

Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study

DOI: 10.1016/j.breast.2022.02.005

Year: 2022

Population-based Study of Cutaneous Malignant Melanoma in the South Region of Portugal: Epidemiological and Clinical Characterization (2016-2017)

DOI: 10.21203/rs.3.rs-723918/v1

Year: 2021

Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal—Results from a population-based cancer registry cohort study

DOI: 10.1371/journal.pone.0258423

Year: 2021

Monitoring real‐life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry

DOI: 10.1002/pds.5163

Year: 2020

298 Prognostic factors for localized uterine carcinosarcoma – 18 years of real-world practice of a portuguese cancer centre

DOI: 10.1136/ijgc-2020-esgo.65

Year: 2020

Real‐world effectiveness of pembrolizumab in previously treated non‐small cell lung cancer: A population‐based cohort study

DOI: 10.1002/pds.5091

Year: 2020

EP37.07: Ultrasonography screening for breast cancer in women above 40 years in the state of Amazonas

DOI: 10.1002/uog.21861

Year: 2019

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

DOI: 10.1016/J.JTHO.2018.08.744

Year: 2018

What are the Sources of Contamination?

How Can Collaboration Improve Data Integration?

How Do These Tools Enhance Data Collection?

How Can Breeding Sites Be Identified?

What is the Role of Epidemiologists in Monitoring Medication Regimens?

What Are the Barriers to Real-Time Collaboration?

What Role Do Peer Reviews Play?

How Does It Affect Epidemiological Studies?

Are There Salary Differences Between Specializations?

How is Data Privacy Managed?

Partnered Content Networks

Relevant Topics